<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> chemotherapy has improved over the years with the advent of newer agents, including more targeted chemotherapeutic drugs, resulting in better patient survival </plain></SENT>
<SENT sid="1" pm="."><plain>However, with continued use and patient exposure to these drugs, important cardiovascular adverse effects are becoming realized, such as left ventricular dysfunction and <z:hpo ids='HP_0001635'>heart failure</z:hpo>, <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">myocardial ischemia</z:e>, <z:hpo ids='HP_0000822'>hypertension</z:hpo>, <z:hpo ids='HP_0011675'>arrhythmias</z:hpo>, and pulmonary arterial <z:hpo ids='HP_0000822'>hypertension</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>In this article, we review the most common cardiovascular toxicities and their related pathophysiology that occur with the use of these agents </plain></SENT>
</text></document>